Retinal Care Data Repository
Launched by RETINAL CARE INC. · Mar 9, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Retinal Care Data Repository is a study designed to collect important information about eye diseases, specifically diabetic retinopathy and age-related macular degeneration. The goal of this research is to use the data to create better tools and treatments for people suffering from these conditions. This trial is not yet recruiting participants, but it aims to include individuals of all ages, from newborns to seniors aged 65 and older, as long as they have diabetes or are in that age group.
If you or a family member have diabetes or are 65 years or older, you might be eligible to participate in this study. There are no specific exclusions, which means that most people who meet the age or health criteria can take part. Participants can expect to contribute to a valuable resource that could help improve care for many others with similar eye conditions in the future. Being part of this study could help advance our understanding and treatment of retinal diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diabetes or age 65 years and older
- Exclusion Criteria:
- • None
About Retinal Care Inc.
Retinal Care Inc. is a leading clinical trial sponsor dedicated to advancing innovative therapies for retinal diseases. With a strong focus on research and development, the organization collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials aimed at improving patient outcomes and enhancing vision health. Committed to scientific excellence and ethical practices, Retinal Care Inc. strives to accelerate the delivery of safe and effective treatments to the market, ultimately benefiting patients suffering from various retinal conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Stephen R Fransen
Principal Investigator
Retinal Care Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials